Compound Detail
CHEMBL2171124
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2171124 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SIXVRXARNAVBTC-UHFFFAOYSA-N |
35
Targets
40
Activities
1
Assay Types
17
PK Parameters
20
Publications
1
Known Names
Molecular Properties
451.4
MW (Da)
4.37
ALogP
5
HBA
1
HBD
77.0
PSA (Ų)
0.50
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 40 meas. best 9.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 9.4 | 8.98 | 0.4 | 3 |
| L929 CHEMBL612267 | IC50 | 9.4 | 9.4 | 0.4 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 3 CHEMBL6030 | IC50 | 9.4 | 9.4 | 0.4 | 2 |
| MEF CHEMBL614342 | IC50 | 8.14 | 8.14 | 7.3 | 1 |
| Receptor-interacting serine/threonine-protein kinase 1 CHEMBL5464 | IC50 | 7.75 | 7.745 | 18.0 | 2 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | IC50 | 6.81 | 6.81 | 154.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.6 | 6.6 | 250.0 | 1 |
| Aurora kinase B CHEMBL2185 | IC50 | 6.39 | 6.39 | 407.0 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 CHEMBL6029 | IC50 | 6.38 | 6.38 | 420.0 | 1 |
| Protein-tyrosine kinase 6 CHEMBL4601 | IC50 | 6.38 | 6.38 | 412.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 10 CHEMBL2873 | IC50 | 6.34 | 6.34 | 452.0 | 1 |
| Tyrosine-protein kinase Mer CHEMBL5331 | IC50 | 6.32 | 6.32 | 474.0 | 1 |
| Discoidin domain-containing receptor 2 CHEMBL5122 | IC50 | 6.28 | 6.28 | 524.0 | 1 |
| Toxoplasma gondii CHEMBL612888 | IC50 | 6.21 | 6.21 | 620.0 | 1 |
| Interferon-induced, double-stranded RNA-activated protein kinase CHEMBL5785 | IC50 | 6.16 | 6.16 | 696.0 | 1 |
| Myosin light chain kinase 2, skeletal/cardiac muscle CHEMBL2777 | IC50 | 6.15 | 6.15 | 701.0 | 1 |
| Cytochrome P450 2C8 CHEMBL3721 | IC50 | 6.05 | 6.05 | 890.0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon CHEMBL3529 | IC50 | 5.97 | 5.97 | 1064.0 | 1 |
| NT-3 growth factor receptor CHEMBL5608 | IC50 | 5.95 | 5.95 | 1115.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 CHEMBL2708 | IC50 | 5.94 | 5.94 | 1140.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 5.92 | 5.92 | 1215.0 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 5.9 | 5.9 | 1250.0 | 1 |
| Serine/threonine-protein kinase Nek4 CHEMBL5819 | IC50 | 5.85 | 5.85 | 1402.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 9 CHEMBL2872 | IC50 | 5.8 | 5.8 | 1578.0 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 CHEMBL4852 | IC50 | 5.8 | 5.8 | 1569.0 | 1 |
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 5.75 | 5.75 | 1756.0 | 1 |
| Tyrosine-protein kinase receptor UFO CHEMBL4895 | IC50 | 5.57 | 5.57 | 2705.0 | 1 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | IC50 | 5.53 | 5.53 | 2962.0 | 1 |
| Tyrosine-protein kinase Yes CHEMBL2073 | IC50 | 5.5 | 5.5 | 3195.0 | 1 |
| Serine/threonine-protein kinase WNK2 CHEMBL5639 | IC50 | 5.41 | 5.41 | 3892.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.35 | 5.35 | 4500.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.16 | 5.16 | 7000.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.0 | 4.945 | 10000.0 | 2 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 4.68 | 4.68 | 21000.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 4.64 | 4.64 | 23000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 6575.8 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1602.1 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3848.5 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3155.3 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 6017.1 | ng.hr.mL-1 | Mus musculus |
| AUC | 839.1 | ng.hr.mL-1 | Mus musculus |
| CL | 21.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 21.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 12.5 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 31.8 | mL.min-1.kg-1 | Mus musculus |
| CL | 21.5 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 100.0 | % | Rattus norvegicus |
| F | 72.0 | % | Canis lupus familiaris |
| F | 62.0 | % | Mus musculus |
| T1/2 | 2.5 | hr | Rattus norvegicus |
| T1/2 | 10.6 | hr | Canis lupus familiaris |
| T1/2 | 2.5 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22827572 | 10.1021/jm300713s | Mus musculus | 8 |
| 22827572 | 10.1021/jm300713s | Rattus norvegicus | 7 |
| 22827572 | 10.1021/jm300713s | Canis familiaris | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22827572 | 10.1021/jm300713s | Eukaryotic translation initiation factor 2-alpha kinase 3 | 3 |
| 22827572 | 10.1021/jm300713s | BXPC-3 | 3 |
| 22827572 | 10.1021/jm300713s | Unchecked | 3 |
| 24900593 | 10.1021/ml400228e | Cytochrome P450 3A4 | 2 |
| 24900593 | 10.1021/ml400228e | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 36346971 | 10.1021/acs.jmedchem.2c01518 | Unchecked | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 22827572 | 10.1021/jm300713s | Mitogen-activated protein kinase kinase kinase kinase 5 | 1 |
| 22827572 | 10.1021/jm300713s | Serine/threonine-protein kinase Nek4 | 1 |
| 22827572 | 10.1021/jm300713s | Mitogen-activated protein kinase kinase kinase 9 | 1 |
| 22827572 | 10.1021/jm300713s | High affinity nerve growth factor receptor | 1 |
| 22827572 | 10.1021/jm300713s | NT-3 growth factor receptor | 1 |
| - | 10.6019/CHEMBL5724564 | Hepatocyte spheroids | 1 |
| 22827572 | 10.1021/jm300713s | BDNF/NT-3 growth factors receptor | 1 |
Data from ChEMBL 36 via Core Engine